slider
slider
slider
slider
slider
slider
slider
slider
slider
slider
slider
slider
slider

Brands QuickVue®

Respiratory Test Kit QuickVue® At-Home OTC COVID-19 Test 2 Tests CLIA Waived

Product # : 1190065 Class : MCKSN Distributor : RELIANCE INC Category : Test Kits Availability : Stocked

$0.00

Product Notices : This product may be non-returnable and/or require additional restocking fee.
Product Varient

Product Specifications

Product No. # 1190065
Manufacturer # 20402
Brand QuickVue®
Manufacturer Quidel
Country of Origin United States
Application Respiratory Test Kit
Number of Tests 2 Tests
Sample Type Nasal Swab Sample
Shipping Width 9
Shipping Height 5
Shipping Depth 1.2
Dimension UOM IC
Shipping Weight 0.15
Weight UOM LB
Contents Individually Wrapped Sterile Foam Swabs, Individually Packaged, (2) Single-Use Test Strips, Pre-Filled Tubes, Tube Holder, Instruction Sheet, Fact Sheet for Individuals
QTY_Per_Sell 1
Simply_Medical_Category Test Kits
Reading_Type Visual Read
Supply_Manager_Category Test Kits
Supply_Manager_Hierarchy Clinical Laboratory>Test Kits>Respiratory Test Kit
Legend_Code No
Stock_Status Stocked
FSA_Eligible Yes
Velocity Slow Selling
UPC 014613339723
Country of Origin United States
Ready to Sell Ready to sell
Other Popular Suggestions
Features
  • Works for symptomatic and asymptomatic individuals
  • The QuickVue At-Home OTC COVID-19 Test is intended for the qualitative detection of the nucleocapsid proteins from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 36 hours between tests.
  • Contains pre-filled vials – no counting of drops or errors in dispensing too much or too little of the liquid reagent solution
  • Positive results indicate the presence of viral foreign agent, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status.
  • Results may help limit the spread of Covid-19 to your family and others in your community.
  • In a clinical study, the QuickVue at Home OTC Covid-19 test identified positive cases 83.5% of the time, and identified negative cases 99.2% of the time.